Olaparib 300mg tablets
D0816C00016
Phase 3 small_molecule completed
Quick answer
Olaparib 300mg tablets for Relapsed Ovarian Cancer is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Relapsed Ovarian Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed